Navigation Links
Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
Date:7/29/2008

ble programs. The most advanced compounds in development include VALSTAR(TM) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly.

Forward Looking Statements

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties are set forth in the Company's filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under "Risk Factors" and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, VANTAS and SUPPRELIN LA; effectiveness of our sales force; competition and its effect on pricing, spending, third-party relationships and revenues; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; risks associated with being a manufacturer of some of our products; risks associated with contractual agreements, particularly for the manufacture and co-promotion of SANCTURA and SANCTURA XR and the manufacture of NEBIDO, VANTAS, SUPPRELIN LA and VALSTAR; reliance on intellectual property and having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement policies and/or rates for SANCTURA, SANCTURA XR, VANTAS, SUPPRELIN LA, DELATESTRYL and any future products; acceptance by the healthcare community of our approved products and product candidates; uncertainties relating to clinical trials, regulatory approval and commercialization of our products, particularly SANCTURA XR, NEBIDO, and VALSTAR; product liability and insurance uncertainties; risks relating to the Redux-related litigation; need for
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Indevus Receives Approvable Letter from FDA for NEBIDO(R)
2. Indevus Announces Management Changes
3. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
4. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
5. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
6. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
7. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
8. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
9. Indevus Announces Allergan as New Partner for SANCTURA Brand
10. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
11. VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... plants survive impact by the huge amounts of ... this energy for photosynthesis. The hypothesis is that ... dissipate the energy throughout the entire protein molecule ... have now managed to successfully ,film, this process. ... proteins which play a role in photosynthesis and ...
(Date:8/27/2014)... , Aug. 27, 2014 ... the "Global Lactic Acid  (Biodegradable Polymer, Food ... Trends & Forecasts to 2019" report to ... simplest hydroxyl-carboxylic acid with an asymmetrical carbon atom. ... the biodegradable polymer, food and beverage, personal care ...
(Date:8/27/2014)... “We are honored to be named ... Thangaraj, CEO of Radiant Sage. “We are offering truly ... imaging corelab market to a different level. We ... to efficiently and effectively manage the massive amounts of ... analyzed and read by trained physicians. Being recognized by ...
(Date:8/27/2014)... 27, 2014 Flagship Biosciences LLC, a ... to the pharmaceutical and medical device industries, has announced ... fast growing company has consolidated its histology and tissue ... to Westminster, CO, just north of Denver. The ... W. 103rd Ave., Suite 100, Westminster, CO 80021 , ...
Breaking Biology Technology:DTU researchers film protein quake for the first time 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Flagship Biosciences Announces Relocation and Expansion 2
... BRIDGEWATER, N.J., April 3, 2012 Hamamatsu Corporation ... previously distributed through third-party dealers, will now be ... 2012, the company is responsible for the sales, ... NanoZoomer product line for new customers throughout North ...
... PHILADELPHIA, April 2, 2012 Echo Therapeutics, Inc. (Nasdaq: ... Symphony® tCGM System as a non-invasive, wireless, transdermal continuous ... transdermal drug delivery, is pleased to announce that its ... at the 72nd Scientific Sessions of the American Diabetes ...
... cellphone you can wrap around your wrist? Such a thing ... James Tour, whose lab has developed transparent, flexible memories using ... today in a talk at the national meeting and exposition ... new type of memory could combine with the likes of ...
Cached Biology Technology:Hamamatsu Corporation Announces Exclusive Distribution of Its NanoZoomer Whole-Slide Scanners 2Echo Therapeutics to Present Positive Clinical Trial Results at the 72nd Scientific Sessions of the American Diabetes Association 2Echo Therapeutics to Present Positive Clinical Trial Results at the 72nd Scientific Sessions of the American Diabetes Association 3
(Date:8/27/2014)... doses of the HIV drug maraviroc, a new study ... before the drug was licensed in 2007, included mostly ... to removing maraviroc from the body. The current study ... including nearly half of African-Americans end up ... who lack the protein even when given the same ...
(Date:8/27/2014)... brain of mice, scientists have altered the emotional ... Howard Hughes Medical Institute investigator Susumu Tonegawa at ... the connections between the part of the brain ... the part of the brain that stores the ... , Altering those connections can transform a negative ...
(Date:8/27/2014)... listen carefully to someone, the first thing we do ... stop moving altogether. This strategy helps us hear better ... , This interplay between movement and hearing also has ... has long suggested that the brain,s motor cortex, which ... rise to our conscious perception of sound. , A ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2Researchers change the emotional association of memories 2Researchers change the emotional association of memories 3Researchers change the emotional association of memories 4Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... are living longer despite cellular defects, a discovery that ... and how doctors could one day limit or reverse ... new University of Colorado at Boulder study. In ... the metabolic state of genetically engineered lab worms called ...
... University in St. Louis are finding common ground between ... embryonic development. Larry A.Taber, Ph.D., the Dennis ... Bayly, Ph.D., Hughes Professor of Mechanical Engineering, are examining ... of the brains surface, or cortex, which gives the ...
... increase in two immune system proteins essential for inflammation to ... that might accelerate cardiovascular disease. The same process ... the elderly. The findings also suggest that chronic ... that can lead to the buildup of plaques clogging coronary ...
Cached Biology News:CU-Boulder worm study sheds light on human aging, inherited diseases 2CU-Boulder worm study sheds light on human aging, inherited diseases 3Engineers study brain folding in higher mammals 2Engineers study brain folding in higher mammals 3Depression, aging, and proteins made by a virus may all play role in heart disease 2Depression, aging, and proteins made by a virus may all play role in heart disease 3
... System - dCTP with CyScribe GFX ... generation and purification of Cy3- and ... for complete cDNA labeling and purification.Flexible ... for performing labeling reactions with either ...
Canine Serum...
UV-NIR light source for USB2000, HR4000, HR2000+...
... EPS 1001 Power Supply, 1. ... maximum.Constant voltage, constant current, and constant ... read-outs for precision and reproducibility.Stores and ... ultrathin flatbed gels on Multiphor ...
Biology Products: